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Background: Seafood is the predominant source of the dietary long-chain omega-3 
polyunsaturated fatty acids (LCn-3PUFA) eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA). Consumption of these fatty acids (FAs) during pregnancy are associated with 
increased neural and visual development in fetus, and decreased risk of postpartum depression 
in mothers. The proportions of DHA in the fetus is positively correlated with the mothers, 
making the maternal intake crucial for fetal levels. There are dietary guidelines for fatty fish 
consumption in relations to its content of EPA and DHA. However, such guidelines does not 
exist for lean fish and cod which is a great source of LCn-3PUFAs, as 200g of cod contributes 
with 480 mg EPA and DHA, double of the daily adequacy level set by the European Food 
Safety Authority (EFSA). 
Objective: To investigate if an increased intake of cod during pregnancy have an impact on FA 
content in red blood cells (RBC), with focus on the marine associated LCn-3PUFAs, in addition 
to evaluating seafood and omega-3 (n-3) supplement intakes. 
Methods: A total of 137 women with prim parous, singleton pregnancy from Bergen, Norway, 
were enrolled in the dietary two-armed randomized controlled trial “Mommy’s Food”. The 
pregnant women were randomized into intervention group consuming 400 gram of cod per 
week, or the control group continuing their habitual diet. The intervention lasted for 16 weeks, 
from gestational week 20 to gestational week 36. A Gas Chromatograph–Flame Ionization 
Detector was used to measure FA content in RBC. Seafood and cod and intake were calculated 
using a food frequency questionnaires (FFQ) and a weight registration form.  
Results: There were no significant differences in the FA content at post-intervention between 
the intervention- and control- group. The intervention group had a significant increase in the 
relative amount of DHA (p<.002) and stability in the n-3 index, with no correlation to cod 
intake. Both groups had a decrease in Σ omega-6 (n-6) and stable Σ n-3 FAs, resulting in an 
increase of the n-3:n-6 ratio. During intervention 71% reported eating seafood for dinner >2-3 
times/week, and 82% consumed n-3 supplements at baseline and post intervention. 
Conclusion: There was no significant difference for the FA content between the groups at post 
intervention. Therefore, in this study, an intervention with dietary cod did not have a significant 
impact on the marine associated LCn-3PUFA in RBC of pregnant women with a high intake of 
seafood and a large percentage taking n-3 supplements. 
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1. Introduction  
A nutritious, well-balanced diet during pregnancy is essential for optimal health and growth of 
the fetus, therefore the quality and nutritional content of the maternal diet is of the utmost 
importance [1]. Seafood is an important source of essential nutrients such as the long-chain 
omega-3 poly unsaturated fatty acids (LCn-3PUFAs), eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) [2]. Higher levels of DHA from seafood intake are in 
epidemiological studies associated with increased neural and visual development in infants, and 
a decreased risk of poor child performance on standardized IQ-test [3-8]. In adults, omega-3 
(n-3) from seafood is found to have protective quality from coronary heart disease (CHD), and 
the recommendation of approximately 1 portion of fatty fish per week is based on this [4, 9, 
10]. The majority of studies concerning seafood and pregnancy are observational, or 
randomized control trials (RCTs) with n-3 fish oil supplementation and not seafood [5, 11]. 
There is a lack of RCTs, the gold standard of studies, on maternal seafood intakes impact on 
fetal health. The RCT Mommy’s food and this thesis could potentially provide new information 
or support existing evidence on seafood intake and pregnancy.  
1.1 Seafood and omega-3 supplements, recommendations and intake   
In this thesis the term seafood denotes invertebrate or vertebrate aquatic animals including fish, 
shellfish and crustacean from marine or fresh water, whether wild or farmed. It excludes aquatic 
mammals, reptiles echinoderms and jellyfish [7]. Seafood is a source of energy, proteins with 
high biological value, and the LCn-3PUFAs; EPA and DHA. It contributes with the intake of 
essential nutrients such as vitamins A, vitamin E, vitamin D, vitamin B12, iodine, zinc, calcium 
and selenium [7, 12]. The nutritional content varies between the types of fish and seafood, a 
fatty fish like salmon contains up to 18 times more n-3 than lean fish such as cod [13].  
1.1.1 Recommendations for seafood and omega-3  
Health authorities recommends a regular intake of fish and seafood to ensure a healthy balanced 
diet, and according to The European Food Safety Authority (EFSA) the recommendations are 
ranging from 100g per week to 200g per day [7]. In Norway fish is the most frequently 
consumed seafood product. The Norwegian Directorate of Health (NDH) recommend eating 
fish for dinners 2-3 times per week and encourage the usage of fish/fish-products as spread. 
The 2-3 fish dinners equal 300-450g of pure fish per week, and 200g or 1.3 portions of this 
should come from fatty fish. Non-fish seafood have no specific recommendations other than it 
is favorable to include it in a balanced diet [9, 10].  
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In Norway pregnant women are recommended to follow the general guidelines for seafood 
consumption, with some limitation to seafood containing higher levels of mercury and other 
undesirable contaminants [14]. EFSA reported that consuming 1-2 and up to 3-4 portions of 
fish/seafood per week during pregnancy is associated with better functional outcomes of neural 
development in children and protection against CHD in adulthood [4, 7].  
There are several recommendations for daily intake of EPA and DHA from different health 
organizations. EFSA set an adequate intake of 250 mg/day of EPA and DHA, which is 
equivalent to 1-2 fish meals per week and based on the protective effect of CHD. An additional 
100-200 mg are recommended for pregnant and lactating women, this is in accordance with 
guideline from the FAO/WHO [6, 7]. The American Heart Association, American Dietetic 
Association and The American Psychiatric Association agreed on a DHA and EPA 
recommendation of 1 g/day. Norway does not have recommendations for dietary intake of EPA 
and DHA for the general population, and the available data is insufficient to set an average 
requirement or a clear tolerable upper intake level [8]. However, the NDH has recommended a 
daily intake of 200 mg of DHA for pregnant and breastfeeding women based on the Nordic 
Nutrition Recommendation [15]. The optimal intake of EPA and DHA is not established, 
however all the aforementioned organization agrees that the n-3 in seafood or supplementation 
is linked to beneficial health outcomes [6-8, 12, 15].  
1.1.2 Health outcomes from seafood and omega-3 supplements 
The influence of seafood in the maternal diet and the fetal development is linked to many 
beneficial health outcomes, though more high-quality studies are needed to establish the 
relationships [12]. Seafood or marine n-3 supplementation during pregnancy is associated with 
positive health outcomes for post-partum depression, pregnancy related nausea, pre-term birth, 
infant sleeping pattern, birth weight, and decreased risk of poor neural and visual development 
in children [3, 6, 8, 16-21]. Pregnant women in Norway, even highly educated, decrease their 
seafood intake during pregnancy [22]. The lower mean intake of seafood amongst pregnant 
women compared to than the general population may be due to a fear of exposure to 
contaminants, or a possible misunderstanding of guidelines [8, 12, 23, 24]. However, 
FAO/WHO agrees that the benefits of consuming seafood during pregnancy outweigh the 




The positive health benefits associated with seafood is largely attributed to the LCn-3PUFAs, 
especially DHA [12, 15, 25]. DHA from seafood is suggested to be the main influencer of the 
improvement in fetal brain and visual development that has been associated with higher intakes 
of seafood [26, 27]. The fetus obtains all of its DHA from the mother trough placental transfer 
and the maternal levels are therefore the main factor of fetal DHA status [28]. Studies with 
mothers consuming n-3 supplements have shown conflicting results on the improvement of 
neural development, and other benefice health outcomes associated with seafood intake. This 
shows that further testing is needed, or there might be other nutrients in seafood contributing to 
the associated health outcomes [18, 29-31]. Iodine is an example of another nutrient that is 
linked to neural development and seafood is found to be a great source of it  [8, 32-34].  
1.1.3 Seafood and omega-3 supplement intake  
The mean fish consumption in Norway is higher than most other European countries such as 
the Netherland, Belgium and Ireland, but lower than countries such as Island, Italy, Spain and 
Portugal [18, 35, 36]. This is shown in the Norwegian Mother and Child (MoBa) Cohort study, 
where the median intake of total seafood per week was 234g, this is 1.6 portions per week based 
on the NDH portions sizes [10, 37]. Of the total seafood intake lean fish constituted 56% and 
fatty fish 34%, the remaining 10 % was form shellfish. The total seafood intake contributed 
with 248 mg LCn-3PUFA per day [13, 37].  
In the average Norwegian population 34% reported using n-3 supplementation, with a mean of 
3 g/day. Pregnant women had a much higher intake of 77%, and the pregnant women using n-
3 supplements had a higher intake of fish than the non-supplement users [8]. Though research 
have shown conflicting results in the efficacy of n-3 supplements to achieve some of the health 
benefits associated with high seafood intake [18, 31]. It is still an effective way of increasing 
the n-3 status of maternal diets low in fish and other DHA and EPA rich foods [38-40]. 
1.1.4 Cod nutrition value 
Fatty fish such as salmon, trout and mackerel are good dietary sources of LCn-3PUFAs, 
however, lean fish including cod is also a good source of DHA and EPA[13]. The cod’s highest 
concentration of n-3 is found in the liver, with 19-29% of the total liver fat content consisting 
of EPA and DHA. There are minor seasonal variations in the fat content, and more so in females 
than males [41]. The cod liver is generally not eaten as it is, but is instead used to make 
supplements such as cod liver oil and n-3 capsules which is an important source to marine n-3 
FAs in the Norwegian diet [12, 38, 42, 43].  
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 A serving of 200g of cod fillet contains 480 mg EPA and DHA, even though the fat content in 
cod fillet is below 2% the n-3 content is double of what EFSA considers to be the daily adequate 
intake [7, 13]. Cod is also a good source of other nutrients, it consists mainly of high-quality 
protein. A serving of 200g of a cod fillet covers about 40% of the daily requirement for vitamin 
B6, vitamin B12, phosphor, and 120% of selenium which some evidence suggest might have 
protective properties against mercury toxicity. 200 gram of cod also contains more than double 
the daily requirement of 250 µg/g of iodine, which many pregnant women have inadequate 
levels of [34, 44, 45]. Cod is therefor a very nutrient rich food to consume in pregnancy. 
1.2 Lipids and fatty acids 
Lipids are essential components of our body composition, and the NDH recommends that 25-
40% of our daily calorie intake come from fats [46]. These hydrophobic organic compounds 
are comprised of hydrogen atoms attached to a long carbon backbone with a small number of 
oxygen substitution [39, 47, 48]. The dietary fat is broken down in the small intestine to lipids 
that are utilized as energy, structure in cell membrane, hormone production and vitamin storage. 
Lipids are commonly classified into three major groups; triacylglycerides (TAG), 
phospholipids (PL) and steroids [39, 47-50].   
TAG is built up of three FAs that are esterified to a glycerol backbone and it is the most energy 
efficient molecule in relations to its size and make up 95% of out dietary fats. PL are structural 
lipids made up of two hydrophobic fatty acid tails connected to the hydrophilic head at the 
glycerol base with its phosphate group. In cod fillet 83.6% of lipids are structural PL [39, 51-
53]. Sterols include cholesterol and steroid hormones, unlike TAG and PL they do not have FA 
tails. [49]. 
1.2.1 Structure and saturation of fatty acids 
FAs are long aliphatic chains with a carboxylic acid at one end as shown in figure 1.1. They 
can be up to 36 carbons long, however most common dietary lipids have between 16-22 
carbons. The FAs are classified as either saturated or unsaturated, depending on the presences 
of the carbon-carbon double bonds (figure 1.1)[39]. The saturated fatty acids (SFAs) have no 
double bonds, while monounsaturated FAs have one double bond and the polyunsaturated fatty 
acids (PUFAs) have between two and six cis double bonds [50, 54]. The unsaturated FAs take 
up more space and makes the cellular membrane more flexible, this is because the double bonds 
cause the FAs to have a kink, meaning they are in a “cis” configuration and cannot be packed 
as tightly as the saturated FAs [39, 47, 53, 55, 56].  
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FAs are characterized by the length and number of carbons. A short-chain fatty acid (SCFA) is 
less than eight carbons long, they are water soluble, and found primarily in dietary products 
containing milk fats [39]. Medium-chains are between 8-14 carbons long, and are found in the 
body as intermediates in FA synthesis or from consumption of coconut oil or dairy fat. The 
long-chain FAs are 15 carbons or more and are the most common ones in the human body, the 
n-3 and omega-6 (n-6) FAs fall in this category [39, 52].  




1.3 Essential fatty acids, omega-3 and omega-6. 
Essential fatty acids (EFAs) are needed to maintain normal development and function, they 
cannot be synthesized by the human body and must be supplied through the diet. Traditionally 
there are two types of FAs that are deemed essential: Linoleic acid (LA, 18:2n-6), the precursor 
for the biologically active arachidonic acid (AA, 20:4n-6) in the n-6 PUFA metabolic pathway. 
The second is α-linoleic acid (ALA, 18:3n-3) a precursor for biologically active EPA (20:5n-3) 
and DHA (22:6n-3) which are the marine associated FAs (figure1.2) [23, 39, 52]. Though only 
LA and ALA are deemed essential, deficiencies of EFAs can be reversed or avoided by 
consuming AA [39, 52]. Also DHA and AA are not made in sufficient amounts by newborn to 
guarantee a normal development, and are considered essential in infant nutrition, pragmatics 





1.3.1 Synthesis, elongating and desaturation of fatty acids 
Through the fatty acid synthesis in the cytoplasm, the body turn acetyl CoA into a FA through 
a series of enzymatic reactions. The end-product of this process is normally palmitic acid (PA) 
(16:0).  PA can be converted into other FA except for EFAs, through the process of elongating 
and/or desaturation [55, 56]. During elongation, the enzyme “elongase” attaches two new 
carbons to the existing FA. The process takes place in the mitochondria using acetyl CoA as a 
substrate, or in the endoplasmic reticulum using malonyl CoA, the most important process is 
elongation of EFAs [55, 60]. ALA and AA is converted into EPA, DHA and AA (and DHA is 
converted back to EPA through retroconversion) in the enzymatic pathway taking place in the 
endoplasmic reticulum utilising β-oxidation, elongase and desaturase enzymes. The reaction 
pathway with intermediate metabolites and enzymes are shown in figure 1.2 [52, 60, 61]. 
Desaturation uses different enzymes depending on the FA, and removes hydrogens to create 
double bonds [55, 60].  
Humans lack the necessary Δ12- or Δ15- desaturase to add a double bond at the 12th and15th 
carbon of a long chain fatty acid to synthesize LA or ALA de novo, and do not have n-3 
desaturase converting enzymes that can convert n-6 to n-3 [3, 62-64]. Subsequently ALA needs 
to come from the diet and be desaturated and elongated by the same enzymes as AL and AA in 
order to be turned into the EPA and DHA. This usage of the same enzyme is the reason for the 
for the competition between n-3 and n-6 in the body (figure 1.2) [3, 39, 65, 66].  Getting n-3 in 
form of EPA and DHA is more efficient than conversion from ALA. In men <6% of ALA is 
converted to EPA and only 0,5% to DHA, women have higher rates with 21% to EPA and 9% 
to DHA [67-69]. The Δ6 desaturase preferred ALA over LA, however abundance of ALA has 
been shown to suppress the conversion of ALA to DHA [70, 71]. Supplementing with the 
intermediate FA sardonic acid to be converted into DHA is found to be more efficient, 
suggesting that Δ6 desaturase could be a limiting factor in the conversion to DHA [71, 72].  
1.3.2 Dietary sources of omega-3 and omega-6 
The dietary sources (table 1.2) of LA are vegetable oils such as sunflower and corn oil. The 
dietary sources of AA are animal products such as meat, game, poultry and eggs. Dietary 
sources of ALA are found in oils from nuts and seeds such as flaxseed, chia, pumpkin seeds 
and walnuts. EPA and DHA are mainly found in seafood especially fatty fish such as salmon, 
mackerel, and sardine, and oils from fish liver, krill and algae [39, 65, 73, 74]. The highly 
insufficient conversion of ALA to DHA is one of the reasons why it is important and 
recommended to consume food containing DHA and EPA such as fish [75]  
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Figure 1.2 Flowchart of the metabolic pathways of omega-3 and omega-6 polyunsaturated 
fatty acids in human, and its dietary sources. Modified from [76] 
 
 
1.3.3 Ratio of omega-3:omega-6 
The genetic patterns of humans were established on a very different diet than what is consumed 
today. The hunter-gatherer diet was lower in n-6 and much higher in n-3 from structural fats 
found in animal brain and fish, subsequently the ratio of n-3:n-6 was close to 1:1 [77]. The 
western diet, consumed in the USA, Europe and Australia, is low in n-3 and excessive in n-6 
FA. The n-3:n-6 ratio of the western diet is between 1:10-1:25, which is much higher than the 
original 1:1 ratio the was biologically intended [65, 78]. A higher level of n-6:n-3 have been 
linked to diseases such as CHD, cancer, allergies, inflammatory and autoimmune diseases, 





Norway have recommendation for the ALA and AL intake, but no recommendation for the ratio 
of n-3:n-6 [8]. However, a panel of lipid experts, where Norway were represented recommend 
a ratio of 1:2. This ratio is in high contrast to the average USA ratio of 1:25 [78, 80, 81]. To my 
knowledge there are no measures of the average Norwegian ratio, but the US, UK, and northern 
European countries are found to have the diets highest in LA and lower levels of n-3 [77, 82]. 
Norway are among the countries with high seafood and n-3 supplementation intake, it is 
therefore possible that the Norwegian population have a higher n-3:n-6 ratio compared to the 
US, the UK, and other northern European countries with western diets [8, 35, 79].  
1.3.4 Associated biological impact of omega-3 and omega-6 fatty acids 
n-3 and n-6 have biological functions in the human body throughout life, impacting the immune 
system, oxygen transport, cell membrane function and neurotransmitter metabolism [23]. DHA 
is one of the most studied FAs in association to fetal development, as DHA deficiencies seems 
to affect brain and eye development [39, 83, 84]. The role of DHA in the retina has not been 
established in its entirety. However, in times of body DHA deficit the retina still contains high 
amounts due to its recycling mechanism, suggesting that DHA is of importance for optimal 
function. Inadequate levels of DHA in human infants are associated with low vision acuity, and 
numerous animal studies found DHA necessary for normal development and retina function. 
DHA is important in the photoreceptor function in retinoid transport and membrane properties, 
as well as regeneration of rhodopsin; a visual pigment in the visual transduction system that is 
responsible for turning the light that hits the retina into the images in the brain [73, 84-86]. 
DHA and AA are fundamental components in the brain and central nervous system (CNS). The 
maternal transfer of DHA is suspected to be higher in the third trimester to meet the fetus’s high 
demands of DHA during the brain growth spurt, the fetal DHA brain concentration increases 
dramatically at this time [87]. The brain consists of 35 % of PUFAs and DHA make up 90% of 
all the n-3, and almost all FAs in the brain is in the form of structural phospholipids [87, 88] 
DHA is concentrated in the frontal lobes which is important in short-term memory, association, 
sustained attention and problem solving [88, 89]. DHA can affect cellular characteristics such 
as membrane fluidity, neurotransmitter release, myelination and neuronal differentiation. DHA 
is a component of myelin sheets which assures that nerve impulse move quickly and efficiently, 
and is in high concentration in the membrane of the synaptic terminals [88]. DHA is found in 
large amount in the gray matter in the brain, and is especially high during development while it 
decreases with age[88]. Numerus studies have found that low levels of n-3 during pregnancy, 
infancy and are associated with poor neurodevelopment and CNS function [3, 73, 84].  
9 
 
The first postpartum year has the higher risk of depression amongst women with 45-65% of the 
women experiencing depression having their first depressive episode [90]. Postpartum 
depression affects both mother and child, as children of mothers with postpartum depression 
are found to have both somatic and psychiatric problems [91-93]. Lower seafood intake and 
DHA levels in RBC is associated with higher frequency of perinatal and postpartum depression, 
though it is EPA that seems most promising in treatment of depression [20, 94-96]. 
 EPA and AA is the parent compounds of eicosanoids, which are a large group of cell-signaling 
molecules. They act upon many different physiological systems and play a large role in immune 
and inflammatory responses [39, 77]. Eicosanoids derived from EPA tend to be less pro-
inflammatory, while those from AA tend to be more pro-inflammatory. Many of EPA derived 
eicosanoids have an anti-inflammatory effect, and therefore less potent inducers of blood vessel 
constriction and coagulation than those from AA. However, some of the AA derived 
eicosanoids are anti-inflammatory as well, so it is an over simplification to label them all as 
pro-inflammatory [39, 73]. Due to the anti-inflammatory effect of n-3 derived eicosanoids, 
consuming n-3 PUFAs are associated with a positive effect on inflammatory diseases such as 
asthma, allergies and rheumatoid arthritis [39, 65, 73, 79]. Thus, a diet high in AA and other  n-
6 FAs and low in n-3 can shift the physiological state to one that is pro-inflammatory [77]. 
Inflammation during pregnancy have been associated with negative health outcomes for 
gestational diabetes, perinatal depression, preterm delivery and preeclampsia [97-99] 
1.3.5 Deficiencies of omega-3 and omega-6 
In 1927, Evans and Burr were the first to establish that a deficiency of fat severely affected 
growth and reproduction [52]. Two years after that, they found that some FAs were more 
important or essential, and that consuming LA or ALA reversed the fat deficiency [39, 52]. 
EFA deficiency is characterized by dry scaly skin, growth retardation, impaired neural 
development, increased susceptibility to infection, poor wound healing, reproductive failure 
and impaired vision. All these symptoms can be complete cured with n-6 alone [87]. Having 
lower levels than recommended does not necessarily lead to presentation of clinical symptoms 
of deficiencies. The cases with deficiency are usually seen in clinical disorders, trauma from 
surgery and some forms of parenteral nutrition [39, 52, 73, 84]. Deficiency or low levels of 
LCn-3PUFA during third trimester brain development have been implicated in the 
pathophysiology of different psychiatric disorders, such as depression [100, 101]. 
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1.4  Fatty acids in red blood cells 
Red blood cells (RBC) or erythrocytes accounts for about 36- 53% of the total blood volume 
and are produced in the bone marrow. They have a flattened biconcave disc shape due to the 
lack of mitochondria and nuclei. The lack of these cellular organelles is the reason for the 
shorter circulation life span of only 120 days [102]. RBC membranes is of particular interest as 
it contains lipids and FAs that are highly affected by the dietary lipids from the diet. Already 
after 10 days of consuming corn oil, an extensive change in the erythrocytes FA composition 
can be observed. Due to RBC life span of 120 days their FA composition is a good indication 
of the dietary FAs consumed the past 4 months. Hence, FA levels in RBC is a good biomarker 
for  evaluating the amount of EFA consumed in the past 4 months [103, 104].  
1.4.1 Omega-3 index 
The n-3 index is a biomarker reflecting the relative amount (%) of sum EPA and DHA within 
the RBC, in research and clinical settings it can be used to document compliance of increased 
LCn-3PUFA intake [105]. A level of >8 means that >8% of the total lipid content in the RBC 
are EPA and DHA, and is considered an n-3 index with greater CHD protection. An n-3 index 
of 4-8% is intermediate protection, and <4 is associated with lower protection [106, 107]. The 
n-3 index varies between dietary cultures more so than ethnicity, as shown in the n-3 index of 
the American and Japanese Americans with an average of 3.2%, while Japanese people living 
in japan had an average of 8.5 % [108]. In a Norwegian study of pregnant women were found 
to have an average n-3 index of 6.4%, this is higher than the US average of 3-6% [20, 105, 108].  
1.5 Changes in mothers to sustain fetal growth, and impact on fetus 
During pregnancy the female body goes through several changes to accommodate and sustain 
the growth of a fetus. There is an increase in energy requirements, blood volume and renal 
plasma flow [39, 52].  The body also have to sustain the creation of a new organ, the placenta. 
It serves as a site of nutrient exchange between the maternal and fetal blood. It has a high 
metabolic rate utilizing about a third of all the glucose supplied by the maternal blood, and the 
rate of protein synthesis is higher than in the liver. It is even more dependent on maternal FA 
contribution due to its poor synthesis of FA. [109, 110]. The health and development of the 
unborn child depends on the habits, health, and the lifestyle of the mother. As the fetus in 
entirely dependent on the mother for all its nourishment through the umbilical cord. Therefore, 
the nutrient composition of the diet is of importance during pregnancy, especially consuming 
nutrient such as n-3 FAs that the fetus in unable to produce itself [23, 52, 84].  
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1.5.1 Fatty acid changes during pregnancy  
Women’s fat deposit increases during pregnancy, together with a change in the homeostasis of 
the fat-soluble and water- soluble nutrients in the plasma, resulting in an increase of fat-soluble 
nutrients and a relative decrease of the water-soluble [52, 54, 111]. The exact physiological 
reasons behind this is not established in its entirety, but are potentially beneficial to the fetal 
development. It takes place in gestational week (GW) 10-12  before the fetus’s needs are too 
demanding on the body and could cause maternal depletion of nutrients [39, 111]. TAG do not 
cross the placenta, but the FAs does and when resembled into TAG in the fetus, it mimics that 
of the mother’s adipose tissue. The fetus get all its EFAs form the mother through the umbilical 
cord and the mother gets her EFAs from the diet. Because of this relationship there is a positive 
correlation between the mothers EFA intake and the fetus’s EFA status [28, 54, 111, 112]. 
During pregnancy there is a steady decline in the maternal DHA and AA status due to a selective 
transfer of these of these FAs to the developing fetus. The transfer is highest in the third 
trimester during the fetal brain spurt [113, 114]. That DHA status is found to be higher among 
first times mothers together with the evidence of mobilization of maternal DHA stores, 
suggesting that the maternal DHA the fetus receives comes from a maternal pool that is not 
easily replenished[114]. N-3 supplementation during pregnancy have been shown to prevent 
decrease and enhancing the maternal DHA status, and the effect of the supplementation have 
been shown to last to 6 weeks postpartum [115]. 
1.5.2 Essential fatty acids in fetus  
Although the fetus can synthesize FAs except EFAs, evidence suggest that as much as 50% of 
the FA requirement are maternally derived [110]. DHA and AA is important structural 
component of the CNS and retina during fetal development, however, they also accumulate in 
other organs. FAs are transferred across the placenta by specific binding of transfer proteins or 
by simple diffusion [28, 54]. These membrane-associated and cytosolic FA binding proteins 
favor n-6 and n-3 fatty acids over non-EFAs and prefers DHA and AA over other forms of the 
EFAs. The transfer proteins facilitate the fetal concentration of higher levels of DHA and AA, 
and lower amounts of LA and ALA [28, 54, 112]. Studies show that supplementing mothers 
with n-3 in form of ALA did not result in higher levels of DHA in fetus, compared to n-3 
supplements or a diet rich in DHA which increases the level in the fetus [116]. Concentration 
of DHA and AA in the fetus is positively correlated with the mothers, it is therefore important 




This thesis is part of the larger study “Mommy´s Food” at the Institute of Marine Research 
(IMR). The main aim is to investigate if an increased intake of cod during pregnancy have an 
impact on maternal iodine status and infant development, in a two-armed RCT with cod for 16 
weeks in the 2nd and 3rd trimester [117]. The aim of this thesis was to investigate if an increased 
intake of cod during pregnancy have an impact on FA content in RBC, with focus on the marine 
associated LCn-3PUFAs, in addition to evaluating seafood and n-3 supplement intakes at 





















The intervention study Mommy’s Food was a two-armed randomized controlled trial. It was 
led and organized by the section of Food Security and Nutrition at the IMR in collaboration 
with the Regional Centre for Child and Youth Mental Health and Child Welfare (RKBU)[117]. 
In this thesis, RBC were utilized to investigate the differences and changes in FA profiles 
between the intervention-group and the control-group in gestational week (GW) 18 (baseline) 
and GW 36 (post-intervention). The weight registration forms of cod intake and food frequency 
questionaries’ (FFQs) were used to investigate seafood intake. 
2.1 Ethics 
The Mommy’s Food trial was registered in ClinicalTrials.gov (NCT02610959) and approved 
by the Regional committees for Medical and Health Research Ethics west (REK Vest, 
2015/879), and complied with the Declaration of Helsinki [117]. Participation in the trial was 
voluntary, and participants could withdraw at any time without stating a reason. A written 
informed consent was obtained from all the participants. Infants do not have the ability to 
consent and therefore have special protection in research, which this study adhered to. All the 
biological samples were optional for both mother and child, and were stored in the IMR 
biobank. Strict confidentiality was upheld for the biological samples and the data collected as 
well as it being de-identified during evaluations, with anonymity for all participants in analyses 
of the data and in any publication of the study [117]. 
2.2 Participants and recruitments 
Participant recruitment was between December 2015 and February 2017. The main recruitment 
site was the Women’s Clinique at Haukeland University Hospital Bergen, where approximately 
5000 women give birth each year. The pregnant women received study information and 
invitation to participate together with their routine ultrasound appointment taking place between 
GW 17 and 19. Appointments were sent out by the Women’s Clinic by postal mail to pregnant 
women in Bergen and greater Bergen area in Health Region West. To ensure sufficient 
recruitment, information and invitation to join the study were broadcasted on common social 
media sites such as Facebook, Instagram and women’s pregnancy magazines. The women 
interested in participating contacted the study secretariat at IMR before GW 19.  
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2.2.1 Inclusion and exclusion criteria   
The inclusion criteria was first time biological mothers with a singleton pregnancy, and had to 
be less than 19 weeks pregnant with Norwegian speaking and writing skills (information, forms 
and validated test of the child were in Norwegian). Exclusion criteria were fish allergies and 
diseases affecting iodine status (Thyroid Nodules, Graves’ disease, know hypo- or 
hyperthyroidism and Thyroiditis) [117]. Chronic disease affecting fatty acid composition and 
not iodine status (E.g. hyperlipidemia) was not in the exclusion criteria, as changes in iodine 
status was the main aim and focus of the study. 
2.2.2 Sample size  
The power calculation for sample size was based on the cohort study “Little in Norway” (LiN) 
with data of urinary iodine concentration (UIC) and daily iodine intake [118]. The power 
calculation is in based on iodine, and not FAs. An intervention-group of 60 participants would 
have a 95% power to detect an iodine content that is 30% higher than that of the control-group. 
Mommy’s food aimed for a total sample size of 144 participants, with a 20% dropout rate 
expected. Enrolment closed with 137 participants where 4 women dropped out before 
allocation, making the intervention-group 68 women and the control-group 65. 
2.2.3 Study schedule and group allocation  
Participants were recruited and started intervention at separate times between February 2016 
and September 2017. Each participant followed the same study schedule with the intervention 
period lasting 16 weeks (Table 2.1). 
To achieve randomization and equal distribution in intervention- and control- groups, 
participants blindly drew group allocation by lottery during their second visit in GW 19 (table 
2.1). The lottery box contained 10 notes, 5 control and 5 intervention. Blinding of the 
participating mothers of group allocation was impossible due to the nature of the study. 
Participant were given a random ID number between 1-200 during baseline sampling, data 
collection and input. A dummy ID during statistical analysis was utilized to ensure further 
blinding of investigators, due to possible exposure of original ID and group allocation during 





Table 2.1 Overview of the study schedule from Mommy’s food, and the main activities that 
are included in the thesis, modified from  [117]. 
 GW<18 GW 18 GW 19 GW 20 GW 36 
ENROLLMENT      
Eligibility screening X     
Informed consent  X    
Instructions  X    
Allocation   X   
INTERVENTION      
Control       
Intervention       
Weight registration forms      
BILOGICAL DATA      
RBC-FA status  X   X 
QUESTIONAIR       
FFQ  X   X 
Abbreviations: GW; gestational week, RBC; red blood cells, FA; fatty acid                         
FFQ; food frequency questionnaire 
2.3 Intervention and food safety     
In the GW 19 visit, the intervention- group received cod fillets for themselves and their live-in 
partner, while the control- group was instructed to follow their habitual diet (table 2.1). The cod 
fillets, skin- and boneless and weighing approximately 200g each, were stored at -30 °C at the 
IMR. The cod was purchased after tender from Lerøy A/S Bergen. The intervention- group was 
given 400g of cod fillets to consume each week and the preparation method was optional. For 
compliance, participants were instructed to weigh (Kitchen Scale, article no. 34–1207-16, 
ClasOhlson.com) the cod fillets raw after thawing and any leftovers from the meal. Preparation 
method, side dish and cod weight were noted in the weight registration form received together 
with the scale and a recipe booklet.   
2.3.1 Safety of cod  
The safety of the food is especially important in vulnerable populations, such as low 
contaminant levels in the food consumed during pregnancy. 400g of cod was calculated to have 
a maximum contribution of 22% of the tolerable weekly intake  (TWI) for mercury (Hg), and 
4% for dioxin and dioxin-like polychlorinated biphenyls (dl-PCB) [117, 119]. The TWI was 
established by the CONTAM panel at EFSA and established to be 1.3 μg/kg for Hg and 14 pg-
TEQ/kg for dioxin and dl-PCB. The maximum intake of unwanted contaminants any one 




2.4 Data collection 
2.4.1 Blood sampling 
Blood sampling was done by a qualified bioengineer from IMR or Betanien, the first sample 
was drawn in GW 18, and again in GW 36, for all participants. The two 
Ethylenediaminetetraacetic acid (EDTA) vials drawn were left for 30-120 minutes. Than 
centrifuged for 10 minutes at 3000 rpm and separate into tubes of serum, plasma, buffy coat 
and RBC. The two RBC sample were labeled with project and participant number, and frozen 
at -80 °C until analysis. 
2.4.2 Food frequency questionnaires   
All participants answered an electronical FFQ in GW 18 and GW 36 about their habitual diet 
during pregnancy. The FFQs were developed to capture iodine rich food and was based on a 
validated semi-quantitative short seafood FFQ that analyses seafood habits in pregnant and 
post-partum women and was developed by Markhus et al [120]. The FFQs consisted of six 
sections; Seafood, milk and dairy products, other parts of diet, food habits, supplements and 
personal social economic questions (appendix I). In the GW 36 FFQ the control- group were 
asked to include consumption of the intervention cod in their answers. 
Seafood question were divided into warm dinner and lunch referred to in the thesis as “warm 
meals”, and spread, salads and snacks referred to as “spread”. The warm meal and spread sub-
sections consisted of questions regarding portions size, and summary- and detailed- 
consumption questions about seafood, fish species and seafood products (table 2.2). 
Participants were asked to answer based on their habitual diet during the past 3 months. Portion 
sizes are stated in standardized portion descriptions for the detail questions. The warm meal 
portion sizes were 150g salmon, 200g cod, 12 sushi pieces, 3 fishcakes, 6 fish balls, 7 fish 
fingers or 2 dl peeled shrimp. The spread portion sizes were one sandwich with either caviar, 
mackerel, smoked salmon, or 1 fish cake. The portion sizes were derived from Norwegian Food 
Safety Authority report “Weight measures and portion sizes” [121]. 
Participants were asked whether they consumed a complete pregnancy supplement containing 
omega-3. If yes, a pop question of brand, frequency and dosage appeared. The supplement 
section also included a question regarding other omega-3 supplements together with or instead 





2.4.3 Converting from seafood frequency and portion to seafood index 
Seafood frequency intake was reported in ordinal data from the FFQ, then converted to 
numerical interval data and further to a seafood index (E.g.: <1 time/month = ordinal data   
0,25 = numerical interval 0,25 = seafood index) (table 2.2, 2.3 and 2.4). This enables 
statistical analysis and aggregation of different types and quantity estimations of seafood 
consumption. The seafood index is based on a validated method developed by Markhus et al. 
[120], and is an estimation of seafood consumption per week, with a seafood index of 1 
representing one portion of seafood per week [121].  
The seafood index for summary questions of warm meals and spreads were based on the 
frequency average per week (table 2.3). There is a tendency of over-reporting low intakes in 
detail questions about individual fish species and seafood consumption [122, 123]. The seafood 
index is therefore the lowest possible weekly intake for warm meals and spread detailed 
questions (table 2.2). Processed fish products has a typical fish fillet content of 40-60% and 
sushi 33%, therefore calculating the seafood index is half or ⅓ of the lowest possible weekly 
intake of processed fish product and sushi (table 2.3)[8]. The seafood index for omega-3 
supplement were based on the average weekly intake, same as the summary questions for warm 
meals and spread (table 2.4).  
Table 2.2 The reported seafood intake frequencies from the FFQs in numerical interval and 
the corresponding seafood index for the warm meals and spread [120]. 
Reported frequency Numerical interval 
per week a 




Never 0 0 0 
< 1 time/month, rarely <0.25 0.15 0.15 
1-3 times/month  0.25-0.75 0.5 0.5 
1 time/week  1 1 - 
1-2 times/week 1-2 - 1.5 
2-3 times/ week  2-3 2.5 - 
3-5 times/week 3-5 - 4 
> 4 times/week  >4 4 - 
> 5 times/week >5 - 5 
Abbreviations: FFQ, food frequency questionnaire  
a Numerical interval based on the average consumption frequency of summery question of seafood 
intake per week as warm and cold meals 
b The seafood index assigned the average weekly intake frequency of seafood as warm meals  






Table 2.3. The reported seafood intake frequencies from the FFQs in numerical interval, and 






Seafood index  
Fish and seafood b 
Seafood index 
Fish products 
c   
Seafood index 
Sushi d 
Never 0 0 0 0 
< 1 time/month < 0.25 0.1 0.05 0.033 
1-3 times/month  0.25-0.75 0.25 0.125 0.083 
1 time/ week  1 1 0.5 0.33 
2 times/week  2 2 1 0.66 
>3 times/week  > 3 3 1.5 1 
Abbreviations: FFQ, food frequency questionnaire  
a Numerical interval based on the average consumption frequency per week of detailed question about 
fish, processed products and sushi as warm and cold meals 
b The seafood index assigned the lowest possible weekly consumption frequency for detailed questions 
about fish and seafood species as warm meals and cold meals  
c The seafood index assigned the lowest possible weekly consumption frequency halved for detailed 
questions about processed fish as warm meals and cold meal. It is halved because processed fish 
products typically contain 40-60% fish[8].   
d The seafood index assigned the lowest possible weekly consumption frequency divided by 3 for 
detailed questions of sushi as warm meals and cold meal. Because ⅓ of the sushi bites are fish[8].  
Table 2.4 The reported omega-3 supplement frequencies from the FFQs in numerical 
interval, and the corresponding seafood index  [120]. 
Reported frequency Numerical interval per week a  Seafood index  
Omega-3 supplements b 
Never 0 0 
1-3 times/month  0,25-0,75 0,5 
1-3 times/week  1-3 2 
4-6 times/week  4-6 5 
Daily  7 7 
Abbreviations: FFQ, food frequency questionnaire  
a Numerical interval based on the average weekly intake frequency of  omega-3 supplements.  
b The seafood index based on the average weekly intake frequency of  omega- 3 capsules, liquid 
omega-3 and cod-liver oil.   
The portions consumed per week were calculated by multiplying seafood index with the 
reported potion sizes. E.g. if a participant consumed 2 portions of fish cakes 1 time/week (50% 
fish, seafood index = 0.5) and one portion of cod fillet 2-3 times/ week (100% fish, seafood 
index = 2.5) the seafood portions per week is 3.5 = (2 potions *0.5 seafood index) + (1 portion 
* 2.5 seafood index). The total seafood intake was the sum of participants frequency and 





2.4.4 Establishing seafood categories 
The types of seafood consumption in the warm meals category was put into groups depending 
on the fat content. Fatty fish had a fat content higher than 5g per 100g = 5%, and the other 
categories had fat content lower than 5% fat or fish containing less than 5% fat, shellfish was 
all <5% [8] (table 2.5). All types of spread were put into one category to simplify analysis.  
Table 2.5 Overview of seafood and fish categories derived from the FFQ, in Mommy’s Food.  
Seafood Category  Type of seafood 
Fatty fish >5% , warm meal Salmon/trout, mackerel, herring, halibut 
Lean fish <5%,  warm meal Cod, pollock, pollack, haddock, common ling and catfish 
Processed fish product warm  
meals <5% fish fat content 
Fishcakes/balls/pudding, fish pie, fish fingers, fish soup,  
Spread  Tinned mackerel, sardine, herring, tuna and salmon, 
smoked or cured salmon and trout, anchovies, peppered 
mackerel lofotpostei, svolværpostei, caviar, crabsticks 
Shellfish and crustaceans 
<5% fat content 
Shrimp, crab claw meat, crabmeat brown, lobster, mussels, 
scallops  
Total fish Salmon/trout, mackerel, herring, halibut, cod, pollock, 
pollack, haddock, common ling and catfish 
Total seafood All fish, processed fish, spread and shellfish listed in this 
table 
Abbreviations: FFQ, food frequency questionnaire  
2.4.5 Intervention compliance  
Dietary compliance was calculated from weight registration forms filled out by the participants 
in the intervention-group showing in grams the amount of the received cod that was consumed. 
Participants registered the weighed of the defrosted cod in grams, which was then subtracted 
by the registered weight of any leftovers to establish the weight of the consumed cod for every 
meal. If the full 200g serving were eaten participants registered cod leftovers as 0g or leaved 
the column blank. Any cod registered that was not supplied by the IMR were changed into zero, 
as other participant might also have eaten non-IMR cod without registered this as per 
instruction, and the weight registration form need to be filled out compatibly for all participants. 
The intervention period lasted for 16 weeks with 400g as the intended weekly intake, making 
the maximum intake of cod 6400g (=16 weeks x 400g) with a compliance score of 100. 
Compliance scores were calculated by dividing the total intake by the maximum intake and 
multiplying it with 100. E.g. a participant with a total cod intake of 4800g or average weekly 
intake of 300g would have a compliance score of 75 ( 4800g/6400g=0.75 x 100= 75) .     
20 
 
2.5 Determining fatty acid composition in red blood cells 
2.5.1 Extraction of fatty acids from red blood cells 
The Hamilton Microlab Star Line (HMSL) robot was used to extract the FAs from the RBC. It 
was operated by a qualified bioengineer with a user-manual course, according to the IMR 
method-description “435-FA with Hamilton Robot and Ultra-GC-FID” (appendix). RBC from 
baseline and post- intervention were taken out of -80 ºC freezer and defrosted on the Gyromini 
Nutating mixer. Participants’ baseline and post-intervention RBC samples were analyzed at the 
same time to ensure there were no method variances or discrepancies. Cleansing water (H20), 
Heptane (C7H16) and Sulfuric acid (H2SO4) were filled into three separate containers and placed 
in its designated spots in the HMSL. Next, four test tubes containing 2 ml of Internal Standard 
(IS) containing 19:0 Methyl, were placed in the robot. A sequence contained 32 RBC samples, 
that were placed into the machine together with a serum with known FAs values and a blank 
(distilled water).  
The HMSL added 60 μl of the RBC samples to the startplate and weighed it to ensure no errors 
occurred, 60 μl of sample serum and the blank was included for quality control. Next, 60 μl of 
the IS and 750 μl of H2SO4 2% in methanol were added. The startplate was sealed and shaken 
at 1200 rpm before being moved to heater-shaker (HHS). Where samples were heated at 105 
ºC and shaken at 100 rpm for 40 min, the last 20 seconds it was shaken at 1000 rpm. The plate 
was cooled down for 15 min, than 250 μl water and 500 μl of hepthan was added and mixed. 
The startplate was than centrifuged for 2 mins at 3000 rpm. A hepthan layer with the extracted 
FA formed, and 300 μl was pipetted by hand into small glass tubes to be analyzed in the Ultra 
Fast Gas Chromatograph–flame ionization detector (UFGC-FID).  
2.5.2 Analysis and integration of fatty acid 
The extracted samples of FAs were analyzed in a UFGC-FID to determine the mg/g sample for 
each individual FA. For quality control 1 sample of heptane, 1 of standard cod liver oil solution, 
2 blanks of distilled water and 2 control samples, were run together with 1 μl of each finished 
sample of FAs in every sequence. The UFGC-FID used gas chromatography to separate the 
FAs compounds and flame ionization to detect the amounts. It gave a readout of the individual 
FA in a chromatogram, where each FA was represented by a peak. The area of the peak 
indicated the amount, and the placement the type of FA. The FAs were decided using an 















Types of 14:00 16:1 16:3n-3 18:2n-6 (LA) 16:2n-4 
Fatty acid 15:00 18:1 18:3n-3(ALA) 18:3n-6 20:3n-9 
Detected 16:00 20:1 18:4n-3 20:2n-6  
In the  17:00 22:1 20:3n-3 20:3n-6  
UFGC 18:00 24:1n-9 20:4n-3 20:4n-6(AA)  
 20:00  20:5n-3(EPA) 22:4n-6  
 22:00  22:5n-3(DPA) 22:5n-6  
   22:6n-3(DHA)   
Abbreviations: UFGC; Ultra Fast Gas Chromatograph-flame ionization detector, PUFA; 
polyunsaturated fatty acid,  
2.5.3 Quality control of fatty acid analysis 
For every sequence of RBC analyzed in the HMSL a control-solution with a known FA 
concentration were analyzed (human plasma). The control-card was made from analyzing 
samples of control-solution ten times, and the FA concentration of 16:0, 18:2n-6 and 22:6n-3 
were the main focus. The readout for the same three FA from the control-solution were put into 
the control-card to get an average of what the FA should be. The control-solution and the whole 
sequence were approved if the average laid within +/-2 standard deviations (SD) of the control-
card average. The IS, 19:0 Methyl, was added in such a concentration that it made up 10-30% 
of the total FA amount. The absolute amount (mg/g) of FAs in the sample was found by 
calculating the area of the individual FA against the area of 19:0 (IS) in the sample that has a 
known value. 
To ensure a correct readout in the UFGC, for a new analysis, a standard solution and Nu-Check 
standard is analyzed first. It has to have a value that varies <5% from the theoretical values and 
sufficient space between the FA peaks for the biological samples to be analyzed. Limit of 
detection or limit of quantification (LOQ) for the method was sat at 0,01 mg/g or 10 µg/g, and 
are the smallest concentration of a quantity that can be reliably measured by this analytical 
procedure [124, 125]. FAs below the LOQ was not included in the results.  
2.6 Statistical analysis 
 IBM SPSS version 25 (IBM Corporation) was utilized for all statistical analyses. Microsoft 
Office Excel or Microsoft Office Word 2013 were used to create tables and figures. P-values < 
.05 were considered statistically significant. Normality was tested for using visual inspection 
with Q-Q plots and histograms.  
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The mean and (SD) were used when the numbers met parametric assumptions. Median and 
interquartile range (IQR) were used when the numbers were non-parametric, interquartile range 
is stated as one number IQR = Q3 − Q1 (Q3=75th percentile and Q1=25th percentile)[126]. 
For the baseline characteristics the mean +/- SD, or participant numbers and percentages were 
found. For the mean (SD) the Mann-Whitney U was used for the non-parametric numbers and 
the independent sample t-test for the parametric numbers. The Chi-square test was used to find 
the n (%). The p-value was not presented as the groups was randomized and there should be no 
statistical significance.  
The FAs were presented in relative amount (%), which was the percentage content of the FA 
out of the total FAs content. The FAs were also given in absolute-amount (µg/g). The FAs were 
non-parametric and was therefore stated in median (IQR). The non-parametric test Related 
Wilcoxon signed rank was used to test for differences within the intervention- group and 
control- group between baseline and post-intervention. While the non-parametric Mann-
Whitney U test were used for differences between the intervention- and control- group at post-
intervention. 
For the FFQ the numbers were non-parametrical and median (IQR) was used or percentages 
where appropriate. The frequency of seafood intake at baseline and post-intervention was stated 
in percentage of participants in each consumption frequency for spread, lunch and dinner. The 
media (IQR) were used for the FFQ seafood intakes with a seafood index as they were non 
parametric. The non-parametric test Related Wilcoxon signed rank was used to test for 
differences within the control- group and intervention- group between baseline and post-
intervention. While the non-parametric Mann-Whitney U tested for differences between the 
control- and intervention- group at post-intervention.  
For the compliance test both mean (SD) and median (IQR) was used together with the minimum 
and maximum intake of cod in grams for each category.  
The non-parametric Spearman’s rank-order correlation was used to test for correlations between 
FAs and seafood or cod intakes from FFQ or weight registration form. There was considered 
very weak correlation with an rs =.00-.199, a weak correlation between rs =.200-.399, moderate 
correlation between rs =.400-.599, strong correlation between rs =.600-.799 and very strong 




3.1 Participation rate  
Figure 3.1 shows an overview of the study population with the dropout and participation rates 
at different stage of data collection. There was a dropout rate of 9.5% (n=13) during the 
intervention period, with RBC- samples collected from 99.2% (n=132) of participants at 
baseline and from 94.4% (n=117) at post-intervention. For the baseline FFQ 92% (n=127) 





3.2 Baseline characteristics  
3.2.1 Demographic of participants at pre-intervention 
Baseline characteristics of the participants are shown in table 3.1. The average age in the study 
population was 29.3 (3.8) years. 86.4% of participants had a higher education at 
university/college level, and 60% attended university/college for more than four years. 
Household income was skewed to the left towards higher values and 63.2% had a combined 
household income of 750 000 NOK or higher. The average body mass index (BMI) for pre-
pregnancy was 23.2 kg/m2 which is within the normal range (18.5-25.0) for adults [128, 129].  
Table 3.1 Baseline characteristics of the pregnant study population from pre-intervention 
FFQ, randomized to intervention- or control- group, in pregnant women in Mommy’s Food. 
 
 






 Physical attributes mean (SD)    
     Age (years) 29.3 (3.8) 29.6 (3.6) 29.1 (3.9) 
     Gestational Age (weeks)  19 (1.3) 19.1 (0.1) 19 (0.1)  
     Pre-pregnancy BMI (kg/m2)  23.2 (4,3) 23.2 (4.0) 23.3 (4.6) 
Cohabitation, n (%)       
     Cohabitation  121 (96.8) 63 (96.9) 58(65) 
     Single or Other 4 (3.2) 2(3.4) 2 (3.4) 
Education level, n (%)    
     Lower secondary school  1 (0.8) 1(1.5) 0 (0) 
     Higher secondary school  16 (12.8) 9 (13.8) 7 (11.7) 
     <4 years university/college 33 (26.4) 18 (27.7) 15 (25) 
     ≥4 years university/college 75 (60) 37 (56.9) 38 (63.3) 
Total household income (NOK), n (%)    
     ≤200,000-349,000 11 (8.8) 5 (7.7) 6 (10) 
     350,000-749,999 35 (28) 19 (29.2) 16 (26.6) 
     750,000-1,249,000 62 (49.6) 32 (49.3) 30 (50) 
     1,250,000->2,000,000 17 (13.6) 9 (13.8) 8 (13.4) 
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3.3 Fatty acid composition in relative- and absolute- amounts 
Table 3.2 and 3.3 shows an overview of median (IQR) of the individual and Σ FAs in relative- 
and absolute-amount at baseline and post-intervention. There was no statistically significant 
changes between the groups at post-intervention for either relative- nor absolute-amount.  
There were statistically significant increases in Σ saturated FA when comparing baseline with 
post-intervention for the relative amount in the intervention- group, and relative- and absolute-
amount for the control- group. There was also a statistically significant increase in Σ unsaturated 
FA for the relative- and absolute-amount in both groups. The 16:0 (PA), 18:1 and 24:1n-9 all 
had statistically significant increased in relative- and absolute-amount between baseline and 
post-intervention for both groups.  
The Σ polyunsaturated FAs had a statistically significant decrease in relative- and absolute-
amount within in the control-group, and absolute-amount within the intervention-group when 
comparing baseline to post-intervention (p<.000).  
There was a statistically significant decrease in Σ n-6, 20:4n-6 (AA) and 22:4n-6 for both 
intervention- and control- group in both relative- and absolute-amounts. The Σ n-3 was stable 
with no statistically significant increase in either group. The intervention-group had a 
statistically significant increase in absolute amount of 22:6 n-3 (DHA) at post-intervention. The 
control-group had a statistically significant decrease in the 22:5 n-3 (DPA) in both relative- and 
absolute- amount. 
There was a statistically significant change in the n-3:n-6 ratio, the Σ n-3 was stable and Σ n-6 
decreased between baseline and post-intervention for both groups. The intervention group had 
higher levels of n-3:n-6 (0.44) in median relative- and absolute-amount, than the control- group 
ratio (0.40). However, there was no statistically significant difference between the groups.  
The n-3 index was a median of 8.4% at baseline and 8.5% at post-intervention for all. However, 
there was no changes within the groups between baseline and post-intervention, and no 







Table 3.2 The absolute amount (µg/g) of the individual fatty acids in red blood cells, for the control- and 
intervention- group at baseline and post-intervention, in pregnant women in Mommy’s Food.  
 All 
 median (IQR) 
 Intervention group 
median (IQR 
 Control group 
 median (IQR 
 In 
Both c 
 Pre Post  Pre  Post p a Pre                 Post  p a p b 
Fatty acid n = 132 n = 117  n = 68  n = 61 in n = 64 n = 58 in btwn 










489 (88) .000 .666 
18:0 SA 290 (70) 300 (65) 300 (68) 300 (80) .436 290 (70) 302 (50) .431 .956 
















18:1 OA 260 (50) 270 (65) 260 (60) 280 (70) .007 265 (45) 270 (60) .012 .991 
24:1n-9 30 (10) 40 (20) 30 (10) 40 (20)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       .017 30 (10) 40 (18) .000 .952 
Σ Unsaturated 308 (65) 323 (77) 306 (71) 322 (80) .003 306 (57) 327 (75) .002 .900 
18:2n-6, LA 190 (50) 190 (60) 190 (47) 180 (55) .411 200 (40) 190 (68)  .734 .545 
20:3n-6 30 (10) 30 (10) 30 (10) 30 (15) .103 30 (10) 30 (10) .678 .305 
20:4n-6, AA 260 (40) 220 (55) 260 (50) 230 (50) .000 260 (38) 220 (60) .000 .904 
22:4n-6 40 (20) 40 (10) 40 (20) 40 (10) .000 40 (10) 40 (10) .000 .939 












20:5n-3, EPA 20 (20) 20 (20) 20 (20) 120 (20) .271 20 (20) 20 (20) .946 .853 
22:5n-3, DPA 40 (10) 40 (20) 40 (20) 40 (15) .813 40 (10) 40 (20) .010 .270 
22:6n-3, DHA 140 (40) 150 (40) 140 (58) 150 (50) .056 140 (30) 150 (38) .176 .189 
n-3 index 155 (52) 167 (53) 155 (64) 170 (54) .137 155 (47) 166 (55) .218 .300 
Σ n-3 203 (66) 216 (72) 203 (76) 225 (65) .258 202 (54) 212 (72) .697 .216 
n-3/n-6 0.38 (10) 
0.43 
(125) 

















Abbreviations: n-6: omega 6, n-3: omega 3,PA: palmitic acid, SA: Stearic acid, OA: oleic acid, AA: Arachidonic 
acid, EPA: Eicosapentaenoic acid, DPA: Docosapentaenoic acid, DHA: Docosahexaenoic acid, n-3 index: Σ EPA 
and DHA, btwn: between, IQR: interquartile range, p: p-value, in: within. 
Fatty acids bellow the limit of quantification <10 µg/g was 15:00, 20:00, 16:1, 20:1, 22:1, 18:3n-6, 20:2n-6, 22:5n-
6 ,16:3n-3, 18:3n-3, 18:4n-3, 20:3n-3, 20:4n-3, 16:2n-4, 20:3n-9, and was therefore not included.  
a Related Wilcoxon signed rank for comparison for differences pre- and post-intervention within the control- and 
intervention- group  
bMann-Whitney U Test for comparison for differences between the control- and intervention- group post-
intervention 
c Difference between groups at post-intervention 






Table 3.3 The relative amount (%) of the individual fatty acids in the total fatty acid content in red blood cells, 
for the control- and intervention- group at baseline and post-intervention, in pregnant women in Mommy’s Food. 
 All 
median (IQR) 
 Intervention group 
median (IQR 
  Control Group 
median (IQR) 
 Both c 
 Pre Post  Pre  Post p a Pre                  Post  p a            p b  
Fatty acid n = 132 n = 117  n = 68  n = 61 In d n = 64 n = 58 in d btwn 
14:0 0.7 (0.2) 0.7 (0.3) 0.7 (0.2) 0.7 (0.3) .010 0.7 (0.3) 0.7 (0.3) .023 .239 
16:0 PA 23.3 (2.1) 24.9 (1.8) 23.5(2.3) 25 (1.8) .000 23 (1.8) 24.8 (2.1) .000 .416 
18:0 SA 15.4 (1.8) 15.3 (1.9) 15.5 (1.6) 15.2 (1.6) .005 15.5 (1.8) 15.5 (2.2) .935 .326 
22:0* 0.4 (0.2) 0.5 (0.2) 0.4 (0.2) 0.5 (0.2) .097 0.5 (0.2) 0.5 (0.1) .002 .102 
Σ Saturated 40.2 (3.7) 42.1 (3.1) 40.8 (3.5) 42.0 (3.1) .001 40.0 (4.4) 42.3 (3.6) .000 .974 
18:1 OA 13.5 (2.0) 13.9 (2.1) 13.3 (1.4) 13.8 (2.1) .000 13.8 (2.1) 13.9 (2.3) .001 .516 
24:1n-9 1.8 (0.5) 2.1 (0.6 ) 1.9 (0.5) 2.1 (.6) .003 1.8 (0.5) 2.2 (0.7) .000 .563 
Σ Unsaturated 16.0 (2.0) 16.6 (2.1) 15.9 (1.6) 16.6 (2.2) .000 16.1 (1.9) 16.7 (2.3) .000 .451 
18:2n-6, LA 10.1 (1.7) 9.9 (1.9) 10.0 (1.7) 9.6 (1.8) .344 10.3 (1.5) 10.2 (1.9) .030 .247 
20:3n-6 1.4 (0.4) 1.4 (0.5) 1.4 (0.5) 1.5 (.5) .672 1.4 (0.4) 1.4 (0.3) .411 .147 
20:4n-6, AA 13.3 (1.7) 11.6 (1.6) 13.2 (1.7) 11.4 (1.5) .000 13.4 (1.7) 11.7 (2.0) .000 .106 
22:4n-6 2.2 (0.7) 1.8 (.6) 2.2 (0.9) 1.8 (.5) .000 2.2 (0.7) 1.8 (.09) .000 .922 
 Σ n-6 27.9 (2.5) 25.5 (2.4) 27.6 (2.6) 25.2 (2.6) .000 28.3 (2.4) 26 (2.6) .000 .124 
20:5n-3, EPA 1.1 (0.8) 1.0 (0.7) 1,1 (0.8) 1.0 (0.7) .190 1.1 (0.8) 1.0 (0.7) .203 .961 
22:5n-3, DPA 2.2 (0.6) 2.1 (0.4) 2.2 (0.6) 2.1 (0.5) .349 2.2 (0.5) 2.1 (0,5) .000 .651 
22:6n-3, DHA 7.3 (1.9) 7.5 (1.7) 7.5 (1.6) 7.7 (1.6) .002 7.2 (2.2) 7.4 (1.8) .080 .917 
n-3 index 8.4 (2.5) 8.5 (2.4) 8.6 (2.5) 8.6 (2.2) .056 8.3 (2.8) 8.3 (2.7) .309 .202 
Σ n-3 10.9 (2.8) 10.9 (2.9) 10.9 (2.6) 11.1 (2.5) .117 10.8 (3.3) 10.7 (3.3) .796 .211 
n-3/n-6 0.38 (0.1) 0.43 (0.1) 0.39 (0.2) 0.44 (0.1) .000 0.38 (0.1) 0.40 (0.1) .005 .085 
Σ Poly-
unsaturated 
38.8 (2,5) 36.7 (2.4) 38.6 (2.2) 36.4 (2.2) .000 39.2 (3.0) 36.7 (2.8) .000 .698 
Abbreviations: n-6: omega 6, n-3: omega 3, PA: palmitic acid, SA: Stearic acid, OA: oleic acid AA: Arachidonic 
acid, EPA: Eicosapentaenoic acid, DPA: Docosapentaenoic acid, DHA: Docosahexaenoic acid, n-3 index: Σ EPA 
and DHA, btwn: between. IQR: interquartile range, P: p-value, in: within. 
Fatty acids bellow limit of quantification <10 µg/g was 15:00, 20:00, 16:1, 20:1, 22:1, 18:3n-6, 20:2n-6, 22:5n-6 
,16:3n-3, 18:3n-3, 18:4n-3, 20:3n-3, 20:4n-3, 16:2n-4, 20:3n-9, and was therefore not included . 
a Related Wilcoxon signed rank for comparison for differences pre- and post-intervention within the control- and 
intervention- group  
bMann-Whitney U Test for comparison for differences between the control- and intervention- group post-
intervention 
c 
Difference between groups at post-intervention 




3.4 Reported Seafood intake baseline and post- intervention  
3.4.1  Summary question from FFQ. 
The summary questions for dinner, warm lunch and spread at baseline and post-intervention are 
shown in figure 3.2 and figure 3.3 as frequency (%) of intake. The highest frequency of seafood 
as dinner were the 43% that reported eating seafood 2-3 times per week, this increased to 69% at 
post-intervention. At baseline, spread was the only category that had a frequency intake of >4 
times a week. At post-intervention all categories were represented in the >4 times/week with 
2.8% for spread, and both dinner and warm lunch went from 0% to 1.9%. The lowest frequency 
for dinner at post-intervention was 1-3 times/month, compared to the 4% at baseline that reported 
consuming seafood for dinner ‘never’ or ‘<1 time/month’. The percentage of spread went up for 
the three lowest frequencies at post-intervention. 
Figure 3.2 Frequency of seafood intake as dinner, lunch and spread at baseline in percentage 






Figure 3.1 Frequency intake of seafood as dinner, lunch and spread at post-intervention in 
percentage from the food frequency questionair, in pregnant women in Mommy’s Food.  
 
3.4.2 Seafood and omega-3 supplement intake  
The seafood intake in portions per week from the baseline and post-intervention FFQ is given 
in table 3.4. The intervention-group had a statistically significant higher intake of seafood as 
dinner, lean fish, total fish, and lower fatty fish than the control-group at post-intervention.  
There was no statistically significant difference in the seafood intake in the control-group 
between baseline and post-intervention. The intervention-group had statistically significant 
increase of lean fish, seafood for dinner and total fish. There was a statistically significant 
decrease of fatty fish, seafood as spread and processed fish. There was however no significant 
change in the total seafood intake either between or within groups. Among the participants 
82.8% reported taking a form of n-3 supplement at baseline, with no change at post-
intervention, and no statistically significant difference between the groups.
30 
 
Table 3.4 The reported seafood intake from the FFQs at baseline and post-intervention, given in portions per week, in pregnant women in 
Mommy’s food trial. 
Abbreviations: interv: intervention, btw: between, in= within. 
 a Related Wilcoxon signed rank for comparison for differences pre- and post-intervention within the control and intervention group. 
 b Mann-Whitney U Test for comparison for differences between the control and intervention group post-intervention 
Seafood categories    All                              
Median (IQR) 
 Intervention group 
Median (IQR) 
P a   Control Group 
Median (IQR) 
P a P b 
Summary question n  Pre interv.  n Post, interv. Pre interv. Post interv. in. Pre interv. Post interv. In. Btw  
  Seafood dinner 127 1.3 (1.8)  107 2.50 (1.25)  1.5 (2.0)  2.5 (0.0)  .000 1.0 (1.7)  1.5 (1.5)  .288 .000 
  Seafood lunch 127 0.2 (0.5)  107 0.15 (0.5)  0.2 (0.5)  0.3 (0.5)  .764 0.2 (.50)  0.08 (.50)  .976 .328 
  Seafood spread 127 1.0 (1.9)  106 0.5 (1.4)  1.0 (1.9)  0.5 (0.9)  .025 1.0 (1.9)  0.8 (1.55)  .761 .632 
Detailed questions             
Warm meal             
   Fatty fish 121 0.6 (0.9)  104 0.4 (0.8)  0.5 (.85)  0.3 (0.4)  .001 0.9 (.9)  0.8 (0.9)  .630 .000 
   Lean fish 123 0.5 (0.8)  105 1.0 (0.7)  0.6 (.90)  1.1 (0.5)  .000 0.5 (0.5)  0.5 (0.5)  .459 .000 
   Cod  123 0.3 (0.4) 106 1.0 (0.8) 0.3 (0.8) 1.0 (0.1) .000 0.3 (0.3) 0.3 (0.3) .566 .000 
  Processed fish  113 0.5 (0.3)  106 0.3 (0.3)  0.5 (0.3)  0.2 (0.2)  .000 0.4 (0.5)  0.3 (0.3)  .003 .118 
Spread            
  Total spread 121 0.9 (2.4)  106 0.8 (1.9)  0.6 (2.3)  0.8 (1.8)  .105 1.0 (2.6)  0.6 (2.4)  .137 .586 
Warm meal & spread            
  Total shellfish   124 0.1 (0.2)  107 0.08 (0.2)  0.1 (0.2)  0.07 (0.2)  .176 0.1 (0.2)  0.08 (0.2)  .538 .493 
  Total fish 120 1.4 (1.2)  104 1.4 (1.1)  1.3 (1.4)  1.5 (0.9)  .001 1.5 (0.9)  1.2 (1.3)  .513 .029 
  Total seafood  114 3.1 (3.9)  100 2.8 (2.8)  3.0 (4.1)  2.70 (2.3)  .258 3.1 (3.7)  2.9 (3.4)  .163 .825 
Supplements n-3, n (%)  n=122  n=106 n=63 n=56  n=59 n=50   
  Yes  101 (82.8)  87 (82.1) 53 (84.1) 46 (82.1) 1.00 48 (81.4) 41 (82.0) 1.00 .985 




3.4.3 Compliance of intervention 
The mean compliance score was 76 and ranging from 35 to 102 as shown in table 3.5. That 
gives a mean total intake of 4884 g out of maximum of 6400 g of cod, the mean weekly intake 
was 305 g. About 50% of the group had a compliance score of 80 or more, and less than 10% 
had a compliance score under 50 (data not shown). 
Table 3.5 The intervention-group’s compliance in consumption of cod from the weight 
registration form during the 16-week intervention period, in the Mommy’s Food trial. 
Compliance of intervention  Mean (SD) Median (IQR) Min-max  
Total intake of cod (grams) 4884 (987.1) 5084 (1279) 2254-6556 
Weekly intake of cod (grams) 305 (62) 318 (80) 141-410 
Compliance score  76 (15) 79 (20) 35-102 
 
3.5 Correlation between fatty acids and seafood, cod and omega-3  
A Spearman’s rank order correlation was run to assess the relationship between the total seafood 
and fish intake, and the relative- or absolute- amount of n-3 index in both groups at post-
intervention. In the intervention-group there was a statistically significant, weak positive 
correlation in the relative-amount, rs = .295, (p<.032), and the absolute-amount rs = .458, 
(p<.001), There was no statistically significant correlation in the control group for the total 
seafood and fish intake and the n-3 index in the relative amount, rs = .245, (p<.109) or the 
absolute amount rs= .280 (p<.065).   
The Spearman’s rank order correlation was also run to assess the relationship between the cod 
intake from the FFQ and the absolute-amount of the Σ n-3 in the groups at post-intervention. In 
the intervention-group there was a statistically significant, weak positive correlation, rs = .359, 
(p<.007). There was no statistically significance correlation in the control group, rs = .206, 
(p<.165). Running a Spearman’s rank order, there was no statistically significant correlation 
between the cod intake from the FFQ and the relative-amount of the Σ n-3 at post-intervention 





A Spearman’s rank order correlation was run to assess the relationship between the cod intake 
from the FFQ and the relative- or absolute- amount of DHA in both groups at post-intervention. 
In the intervention-group there was a statistically significant, weak positive correlation between 
the cod intake from the FFQ and the absolute- amount of DHA, rs = 0.334 (p<.013). However, 
this correlation was not observed between the cod intake from the FFQ and the relative- amount 
of DHA, rs = 0.098 (p<.477). For the control group there was no statistically significant 
correlations between the cod form the FFQ and DHA absolute-amount rs = 0.199 (p<.179) or 
DHA relative-amount rs= 0.060 (p<.688). 
Spearman’s rank order correlations were run again to assess the relationship between the total 
cod intake from weight registration forms and relative- or absolute- amounts of DHA or Σ n-3 
for both groups at post-intervention. There was found no statistically significant correlation 

















Seafood is a good source of the LCn-3FAs EPA and DHA, and during pregnancy higher levels 
of DHA has been linked to beneficial health outcomes for mother and child [130, 131]. There 
is currently lacking in RCT studies of seafood intake during pregnancy and FAs, and the 
existing ones does not focus specifically on FAs in relation to lean fish [5, 11]. Consequently, 
this thesis may shed some light on what impact lean fish consumption in pregnancy have on 
marine associated LCn-3FAs. The overall aim of this thesis was to investigate if an increased 
intake of cod during pregnancy have an impact on FA content in RBC, with focus on the marine 
associated LCn-3PUFAs, in addition to evaluating seafood and n-3 supplement intakes at 
baseline and post- intervention. In the two-armed RCT Mommy’s Food study the FA content 
was measured by UFGC-FID, and seafood intake reported in FFQs at baseline and post-
intervention. The intervention-group were instructed to consume 400g of cod between GW 20-
36, while the control-group continued their habitual diet. 
4.1 Discussion of main findings  
There were no significant changes between the intervention- and control-group FA statuses at 
post-intervention, respectively. There were however significant changes within both groups, 
between baseline and post-intervention. There were significant decrease in Σ n-6 FAs seen in 
both groups for the relative- and absolute- amounts, this is likely due to the maternal decrease 
in n-6 FAs commonly seen in the last trimester [115]. Women are also known to have this 
progressive decline in DHA and other n-3 FAs during pregnancy due to the increased demands 
of the fetus in the 3rd trimester [114, 115, 132].  However, this DHA, Σ n-3 and n-3 index decline 
was not present in either the control- or intervention-group. The n-3 index levels stayed 
desirable and stable without significant changes within, or between the groups. The intervention 
group had a statistically significant increase in the relative-amount of DHA between baseline 
and post-intervention. The n-3:n-6 increased for both groups, likely linked with the decrease in 
Σ n-6 and stability in Σ n-3.  
4.1.1 Increase in relative-amount of DHA in the intervention group  
During pregnancy there is a decrease in the maternal DHA due to a selective transfer of this FA 
to the developing fetus, and transfer is highest in the third trimester when the post-intervention 
blood sample was drawn (GW 36) [113, 114]. In the current study this pattern was not observed. 
The intervention group had a significant increase in the relative-amount of DHA from 7.5% to 
7.7% (p<0.002), though the increase was not significant in absolute-amount.  
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The DHA levels of the control group did not have a statistically significant increase, and there 
was no significant difference between the groups. The increase in the maternal DHA indicates 
that the intervention group had a higher n-3 intake than reported in other studies where maternal 
decline is present. The higher n-3 intake enabled the mother to meet the fetus’ increased demand 
without depleting the maternal DHA storage [113, 115]. The maternal EPA and DHA levels 
are found to be reflected in the n-3 status of the fetus. Therefore, a good maternal DHA level 
without decline would indicate that the fetus’ status is good and it is getting adequate DHA 
levels during development [28]. High maternal DHA in pregnancy is associated with better 
vision acuity and brain development in the fetus, as large levels of DHA resided in both the 
brain, CNS and the retina[133]. Having an increase in the 3rd trimester is especially good as this 
is the time of increased fetal demands due to the brain growth spurt. Children of mother with 
good DHA levels are seen to have a higher birth weight, and higher scores on standardized IQ 
tests [3, 84-88]. In the mothers, higher DHA levels are associated with lower levels of preterm 
delivery, inflammation, and postpartum depression [2, 5, 61, 84, 130]. The increase in DHA 
levels in the intervention group, and stability in DHA levels of the control group is therefore a 
favorable outcome. 
Cod is a good source of LCn-3PUFAs, as one portion of 200g contains double the daily 
adequate level of EPA and DHA set by EFSA [7, 13]. The increase in DHA levels seen only in 
the intervention group suggested that cod could be an influence, as it was the only reported 
DHA source to significantly increased during the intervention-period. The cod intake from the 
FFQ or the cod intake from the weight registration form, and relative- or absolute- amount DHA 
level was tested for a correlation. There was no correlation between the cod intake from weight 
registration forms or the FFQ and the significant increase in the relative-amount of DHA. There 
was a weak correlation between the absolute-amount of DHA and FFQ cod intake. However, 
this correlation was not seen between the absolute-amount of DHA and the actual cod intake 
from the weight registration forms. As the cod intake from the weight registration forms are 
more accurate than the FFQ there is likely no relationship between the cod intake and the 
absolute amount of DHA. The cod intake was therefore not correlated with the increase seen in 
the relative-amount of DHA or the stability in the absolute-amount, in the Mommy’s Food 
study. The n-3 supplementation can be a possible explanation for the increase in the relative-
amount of DHA. As it is found to be an effective means to retain maternal DHA levels during 




4.1.2 Stability of the Σ omega-3 and omega-3 index in both groups 
An n-3 index of >8% is associated with greater cardio protection and is set as the desirable n-3 
index. While 8%-4% is considered to offer intermediate protection and <4 is considered to have 
lower protection [134]. Though an index of <5% is still found to reduce the risk of primary 
cardiac arrest with 70% [107, 135]. The intervention- and control- group had the same median 
n-3 index at both baseline and post-intervention, with no significant difference between or 
within the groups. Both groups had an n-3 index >8%, meaning they had an optimal level of 
EPA and DHA in relation to CHD and other n-3 associated health benefits [134]. 
The stability and high n-3 index present in both groups indicates a supplementation habit or a 
diet rich in EPA and DHA. When testing for a relationship between the n-3 index and seafood 
intake from the FFQ the intervention-group had a weak positive correlation. However, no 
correlation was seen in the control group. The intervention-group’s n-3 index was than tested 
for a correlation with the cod intake. The same correlation pattern seen in cod intake and DHA 
was present. There was no relationship between the increase in n-3 index relative-amount and 
the cod intake from the FFQ or the cod intake from the weight registration form. There was 
however a weak positive correlation between the FFQ cod intake and the n-3 index absolute-
amount. This indicates the same as with DHA, that there is no correlation between the dietary 
cod intake and the stability in n-3 index. The intervention groups had a weak correlation unlike 
the control group, indicating that the seafood consumed in the intervention group have a large 
impact on the n-3 index than the seafood in the diet of the control group, despite the fact the 
intervention cod was not correlated. The control group’s EPA and DHA was not correlated with 
the seafood intake and therefore suggesting that the n-3 supplementation is responsible for the 
high n-3 index in this group.  
The study population had a median n-3 index of 8.4% at baseline and 8.5% at post intervention 
which was higher than the average previously found in Norwegian pregnant women of 6.4%, 
and US average between 3%-6% [20, 105, 108, 136, 137]. An n-3 index can be used as a 
biomarker to check for compliance of n-3 intakes from supplement or diet [105]. A higher than 
average n-3 index such as in this study population would therefore indicate intakes of  LCn-
3PUFAs that was higher than average population, at both baseline and post intervention [20]. 
The lack of decline in Σ n-3 FAs and a desirable stable n-3 index such as the study group had 
throughout their pregnancy, is associated with the same beneficial health outcomes as 
aforementioned with a higher level of DHA [87]. 
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4.1.3 Increase in the omega-3:omega-6 ratio  
AA, like DHA is important for brain and retinal development during gestation, though a much 
higher levels of n-6:n-3 is not beneficial for the health as the humans evolved on a ratio closer 
to 1:1 [77, 138]. There was a significant increase in the n-3:n-6 ratio for both groups between 
baseline and post-intervention. The main influencer of the change in ratio is likely owing to the 
significant decrease of the Σ n-6 FAs. When the diet is rich n-3 the n-6 levels in the body have 
been known to decrease, though in this study the n-6 decrease is likely due to the maternal 
decline commonly seen in the last trimester [113, 114]. Since there were significant increases 
for the n-3:n-6 ratio seen in both groups, and no significant difference between the two it is 
likely due to metabolic and dietary factors present in both groups. Therefore the dietary cod is 
unlikely to be the reason for the significant increase in the n-3:n-6 ratio. The study population 
had a n-3:n-6 ratio at baseline and post-intervention that was close to 1:2 (= 0.5 μg/g, 0.5%). A 
ratio of 1:2 is higher in n-3 than that associated with an average western diets, which ranges 
from 1:10 up to the American average of 1:25 [78, 80]. The study population’s ratio is desirable 
as it is the recommended ratio of n-3:n-6 set by a panel of lipid experts [81]. Higher levels of 
n-3:n-6, like the ones in the study population, is associated with beneficial health outcomes for 
childhood obesity, neural development and CHD. As well as being less inflammatory due to 
higher levels of n-3 derived anti-inflammatory eicosanoid and cytokines, which is associated 
with lower levels of autoimmune diseases, asthma, eczema and allergies  [2, 77, 79, 139-141].  
4.2 Discussion of findings in seafood intake and study population  
4.2.1 Changes in seafood intake reported from the food frequency questionnaire 
The significant differences seen in seafood intake at post-intervention between the intervention- 
and control- group can all be linked to the intervention group’s increased intake of cod. The 
control group followed their habitual diet during the intervention period and had no significant 
differences between their baseline and post-intervention seafood intakes. The intervention 
group’s increased intake of lean fish resulted in a significantly lower intake of fatty fish, they 
went from consuming 0.5 portion of fatty fish per week to 0.3 portions per week. This is not 
desirable as the NDH recommends half of the of 2-3 portions of fish per week to come from 
fatty fish, in order to achieve the recommended amount of  EPA and DHA [10]. However, there 
was no reduction in Σ n-3 FAs or the n-3 index despite the decrease in the fatty fish intake. This 
means that the intervention group was getting adequate levels of EPA and DHA and would still 
have protection against CHD despite reduction in fatty fish intake. 
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EFSA concluded that a fish/seafood intake of 1-2 up to 3-4 portions per week during pregnancy 
was associated with better neural development and protection against CHD [7]. The majority 
of the study population followed this advice, as 73% at baseline and 91% at post-intervention 
reported eating seafood for dinner >1 time/week. The reported frequency of seafood for dinner 
increased at post intervention, as 71% reported consumed seafood for dinner > 2-3 times/week 
compared the 43% at baseline. In addition at post intervention 38% reported eating seafood as 
spread > 1 time/week, and 24% eating seafood as warm lunch > 1 time/week.  
4.3 Discussion of method, limitation and strengths 
4.3.1 High intake seafood and omega-3 supplement in the study population   
The women of study population had a high intake of seafood and n-3 supplements as shown in 
the n-3 index, and the higher than average social-economic status is a possible explanation for 
this. As 86% of participants had a higher education, this was more than double of the national 
average 37% for women [142]. The national average household income for couples with 
children of 0-6 year is 743 000 NOK, and couples without children under the age of 45 is 
586 000 NOK. This falls within the household income category of 350 000-749 999 NOK, 
where only 28% of the study population reported their combined household income to be [143]. 
In addition, 63% reported a household income between 750 000 NOK and up, which is above 
the national average in both categories. The average age was the same as the Norwegian average 
age for first time mothers of 29 year [144]. A higher social-economic status is associated with 
a healthy habits such as taking recommended supplements and higher intake of healthy foods 
such as fruit, vegetable and fish, and this may explain the high baseline intake of seafood and 
n-3 supplements in this study population [145, 146].  
Another possible explanation for the high seafood intake is that the study required participants 
in the intervention group to consume cod twice a week. This requirement would not have the 
same appeal to women who never eat fish compared to the women regularly consumed fish. 
This is shown in the 99.2% of women who reported eating seafood for dinner at baseline. The 
NDH have no n-3 recommendation for the general population, but recommends pregnant 
women to consume 200 mg/day of DHA, possibly explaining why the pregnant study 
population have a high n-3 intake [147]. Having a baseline population with high intake of 
seafood and n-3 supplements containing LCn-3PUFA makes it hard to assess the impact of 
dietary LCn-3PUFA from cod.  
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4.3.2 Presentation of relative- and absolute amount of fatty acids.  
FAs were presented in both relative- and absolute- amount. When there is no clear methodology 
of which to use it can be beneficial to present both [148, 149]. Presenting FA as relative- or 
absolute- amounts can yield different results. When Mocking (2012) analyzed the difference 
between the two using a Pearson’s correlation, he found the correlation to vary from rs = 0.3 to 
rs = 1.0 for the same FA. The variation is greatest when the FA is strongly correlated to the total 
FA concentration [148]. This is seen in the results for the intervention group’s 18:0 (stearic 
acid) which makes up a large part of the concentration (15% and 300 μg/g) and have a large 
variation in the p-values at post-intervention for the relative amount (p<.005) and absolute 
amount (p<.436). 
4.3.3 The impact of omega-3 supplementation. 
Throughout the study ≈82% of the study population were taking n-3 supplementation. This was 
7% higher than the national average for pregnant women, and 47% higher than the national 
average for adults [8]. There were no changes in the amount of women taking supplement 
between baseline and post-intervention (p<1.000) or between the groups (p<.985). However, 
the amount and frequency of n-3 supplementation was not taken into consideration during 
statistical analysis, only whether participants were taking supplements or not. Due to this the 
actual amount of n-3 provided from supplements could vary between participants, groups, and   
between baseline and post-intervention. It is therefore difficult to say how large an impact the 
n-3 supplementation has on the n-3 FA status. As n-3 supplements have been found to increase 
the n-3 status during pregnancy, and the control group’s n-3 index was not correlated with 
seafood intake, the high n-3 supplement intake in the study population might be responsible for 
the stability observed in n-3 FAs [115]. Optimally, in order to find the true impact of cod and 
seafood on marine associated n-3 FAs, neither group would take supplementation, but that is 
not ethically possible as pregnant women are recommended by EFSA to get 350-450 mg/day 
of EPA+DHA per day, and 200mg/day of DHA by the NDH [7, 147]. 
4.3.4 Seafood-index calculation of dietary cod 
Getting self-reported intake from an FFQ is a relatively inexpensive method as, it is easier for 
participants to undertake and does not require trained interviewers [150]. However, FFQs are 
also prone to over- and under- reporting [151]. It is therefore important to use a validated FFQ 
which is a strength of this study, as the FFQ is based on a validated seafood-FFQ [120].  
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The lowest consumption frequency was used when calculating the seafood index in the detailed 
questions, because of a tendency among participants of over reporting intakes when asked 
detailed questions about specific seafood species [121]. This was in accordance with the method 
[120]. When participants reported eating cod 1-2 times per week that was be calculated as 1 
time per week, and one portion of cod equals 200g. The intervention group’s reported median 
intake of lean fish was 1.1 portion per week equaling a maximum of 220 grams of cod. The 
median intake of cod was also calculated from the weight registration forms to be 318 g or 1,6 
portions of cod per week. The difference seen between the reported intake from the FFQ, and 
the median intake from the weight registration forms indicated that the method underestimates 
the cod intake for the intervention group. This is further supported by the compliance score 
showing less than 10% had a compliance score under 50, which is 1 portion of cod per week. 
Therefore, most of the participants likely had intake closer to 2 portions per week than 1 portion 
per week. Cod was such a large part of the intervention group’s seafood intake that an 
underestimation would affect the other calculations from detail question such as total seafood 
and fish intake. Using an average intake instead of the lowest frequency could result in a cod 















In conclusion, there was no significant difference for the FA content between the groups at post 
intervention. Therefore, in this study, an intervention with dietary cod did not have a significant 
impact on the marine associated LCn-3PUFA in RBC of pregnant women with a high intake of 
seafood and a large percentage taking n-3 supplements. There was a significant increase in the 
intervention group’s relative-amount of DHA, though this was not correlated with the intake of 
cod. A plausible explanation for the increase, is the high percentage of women taking n-3 
supplement, though further testing is needed to establish this.  
There was a significant decrease in the Σ n-6 within both groups between baseline and post-
intervention. This was likely due to the increased demand from the fetus in the third trimester 
rather than dietary changes [113, 114]. The Σ n-3 was stable for both groups meaning the 
mothers had adequate dietary intakes to maintain the LCn-3PUFA level. The stable and higher 
than average n-3 index of >8% for both groups indicate a diet rich and above average in LCn-
3PUFAs at both baseline and post-intervention. The increase seen in the n-3:n-6 ratio was likely 
due to the decrease in n-6 status, and assisted by the stable n-3 status.  
The study population had a high intake of seafood and n-3 supplementation, possibly due to the 
higher social economic status. There was a change in the seafood intake of the intervention 
group; the increased cod intake resulted in a reduction in fatty fish intake, this did not negatively 
impact the n-3 levels. A possible underestimation of the cod intake in the intervention group 
for the detail question when comparing it to the weight registration forms was seen.   
4.5 Future perspectives  
This thesis provides new information about dietary cod’s impact on marine associated LCn-
3PUFAs status in pregnant women with a habitual diet relatively high in n-3. Future studies 
should have a larger study population that assess the impact of cod on pregnant populations 
with a habitual diet closer to the average n-3 intake, which would be more representative of the 
general Norwegian population. A future studies could also test the impact of cod consumption 
in other populations than pregnant women, as the impact might be different during pregnancy 
due to physiological changes. In a larger study it could be beneficial to calculate the exact n-3 
supplementation intake, as it can have a large impact on the marine associated LCn-3PUFA 
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 Appendix I: Questionnaire (FFQ) post-intervention  

























































































































Appendix II: IMR Protocol 435 - FA with Hamilton robot and UFGC-FID  
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